Logo Logo
Switch Language to German

Mittermeier, Andreas ORCID logoORCID: https://orcid.org/0000-0001-5743-473X; Ertl-Wagner, Birgit; Ricke, Jens; Dietrich, Olaf ORCID logoORCID: https://orcid.org/0000-0001-6182-5039 and Ingrisch, Michael ORCID logoORCID: https://orcid.org/0000-0003-0268-9078 (2019): Bayesian pharmacokinetic modeling of dynamic contrast-enhanced magnetic resonance imaging: validation and application. In: Physics in Medicine & Biology, Vol. 64, No. 18, 18NT02 [PDF, 1MB]


Tracer-kinetic analysis of dynamic contrast-enhanced magnetic resonance imaging data is commonly performed with the well-known Tofts model and nonlinear least squares (NLLS) regression. This approach yields point estimates of model parameters, uncertainty of these estimates can be assessed e.g. by an additional bootstrapping analysis. Here, we present a Bayesian probabilistic modeling approach for tracer-kinetic analysis with a Tofts model, which yields posterior probability distributions of perfusion parameters and therefore promises a robust and information-enriched alternative based on a framework of probability distributions. In this manuscript, we use the quantitative imaging biomarkers alliance (QIBA) Tofts phantom to evaluate the Bayesian tofts model (BTM) against a bootstrapped NLLS approach. Furthermore, we demonstrate how Bayesian posterior probability distributions can be employed to assess treatment response in a breast cancer DCE-MRI dataset using Cohen's d. Accuracy and precision of the BTM posterior distributions were validated and found to be in good agreement with the NLLS approaches, and assessment of therapy response with respect to uncertainty in parameter estimates was found to be excellent. In conclusion, the Bayesian modeling approach provides an elegant means to determine uncertainty via posterior distributions within a single step and provides honest information about changes in parameter estimates.

Actions (login required)

View Item View Item